HEALTH CATALYST, INC. (HCAT): Price and Financial Metrics
HCAT Price/Volume Stats
| Current price | $6.03 | 52-week high | $14.37 |
| Prev. close | $5.60 | 52-week low | $5.45 |
| Day low | $5.53 | Volume | 692,600 |
| Day high | $6.07 | Avg. volume | 616,317 |
| 50-day MA | $7.44 | Dividend yield | N/A |
| 200-day MA | $9.31 | Market Cap | 353.13M |
HCAT Stock Price Chart Interactive Chart >
HEALTH CATALYST, INC. (HCAT) Company Bio
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. The company is headquartered in Salt Lake City, Utah.
Latest HCAT News From Around the Web
Below are the latest news stories about HEALTH CATALYST INC that investors may wish to consider to help them evaluate HCAT as an investment opportunity.
Why Are Health Catalyst (HCAT) Shares Soaring TodayShares of healthcare software provider Health Catalyst (NASDAQ:HCAT) jumped 6.5% in the morning session, reflecting the broader market's ongoing uptrend, which some may playfully call the Santa Claus rally (a real observed phenomenon where the market tends to drift upwards during the holiday season for reasons such as optimism and year-end tax considerations for funds and investors). All major indices rose, fueled by growing optimism about the Federal Reserve not only concluding its rate hikes b |
Health Catalyst to Participate in Upcoming Investor ConferenceSALT LAKE CITY, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, will participate in the 42nd Annual J.P. Morgan Healthcare Conference, being held in San Francisco. In conjunction, there will be a pr |
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 49% Below Their Intrinsic Value EstimateKey Insights Using the 2 Stage Free Cash Flow to Equity, Health Catalyst fair value estimate is US$16.28 Health... |
Health Catalyst's Analytics Solutions Save WakeMed Health & Hospitals $10 Million, Accelerates Clinical TransformationHealth Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced WakeMed Health & Hospitals ("WakeMed") has achieved $10M variable cost reduction by decreasing unnecessary care variation while helping to improve care quality. |
Health Catalyst to Participate in Upcoming Investor ConferencesSALT LAKE CITY, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, will participate in the following upcoming investor conferences: Piper Sandler 35th Annual Healthcare Conference, being held in New York, on Wednesday, November 29, 2023, |
HCAT Price Returns
| 1-mo | -18.95% |
| 3-mo | -41.46% |
| 6-mo | -12.10% |
| 1-year | -50.90% |
| 3-year | -89.31% |
| 5-year | N/A |
| YTD | -34.88% |
| 2023 | -12.89% |
| 2022 | -73.17% |
| 2021 | -8.98% |
| 2020 | 25.45% |
| 2019 | N/A |
Loading social stream, please wait...